Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Healthcare
Innocan Pharma Corporation is an Israel-based pharmaceutical company active in the medical cannabis industry. It operates through three distinct operating segments: Research, Development, Marketing, Distribution and sales of InnoCan-branded over the counter (OTC) pharmaceutical products; Research and Development of Non-pharmaceutical products for third parties and Research and Development of... see more

Recent & Breaking News (CSE:INNO)

Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT)

Newsfile August 3, 2021

Innocan Pharma Announces the Filing of a Patent Application for the Treatment and Prevention of Hair Loss

Newsfile July 28, 2021

Former Israeli Minister of Science and Technology and Highly Influential Venture Capitalist to Join Innocan Pharma's Advisory Committee

Newsfile July 14, 2021

Innocan Pharma Announces Filing of International Patent Application for Topical Treatment for Diabetic Symptoms

Newsfile July 9, 2021

Innocan Pharma and Health Investment Group S.A. Sign Exclusive Distribution Agreement for Poland

Newsfile July 1, 2021

Innocan Pharma's CBD Integrated Anti-Aging Sleeping Mask Demonstrates a Reduction of the Appearance of Wrinkles by up to 28.8% in 4 Weeks of Clinical Study

Newsfile June 24, 2021

Innocan Pharma Corporation to Webcast Live at Life Sciences Investor Forum June 24th

GlobeNewswire June 21, 2021

Clinical Study Validates Innocan Pharma's SHIR(R) CBD Eye Serum as an Anti-Puffiness Solution

Newsfile June 16, 2021

Innocan Pharma Announces Patent Application for Novel Cannabis-Based Vaginal Moisturizer and Lubricant Treatment

Newsfile June 14, 2021

InnoCan Pharma tests (CSE:INNO) Liposome Platform Technology for CBD

Trevor Abes  June 11, 2021

Innocan Pharma's Liposome Platform Technology Demonstrates a 7-Week Prolonged Release of CBD into Bloodstream in Recent Animal Study

Newsfile June 11, 2021

Innocan Pharma Among Leading CBD Pharma Companies to Participate at Lytham Partners Summer 2021 Investor Conference

Newsfile June 9, 2021

Innocan Pharma’s (CSE:INNO) CBD loaded liposome platform technology receives positive results

Brieanna McCutcheon  May 14, 2021

Innocan Pharma's CBD Loaded Liposome Platform Technology Receives Positive Results from Recent Animal Study

Newsfile May 14, 2021

Innocan Pharma Engages Lytham Partners to Lead Investor Relations and Shareholder Communication Program

Newsfile May 10, 2021

Innocan Pharma Announces Trading on the OTCQB Venture Market and DTC Eligibility of Its Common Shares in the United States

Newsfile May 6, 2021

Innocan Pharma and Polyflame Announce an Exclusive Distribution Agreement in France

Newsfile April 22, 2021

Richard Serbin, Former Johnson & Johnson's VP and a Leading Global Strategy Advisor in the Healthcare Industry, to Join Innocan Pharma's Scientific Advisory Committee

Newsfile April 6, 2021

Innocan Reports Q4 2020 Financial Results

Newsfile April 1, 2021

Dr. Mitchell Kline joins Innocan Pharma’s (CSE:INNO) Scientific Advisory Committee

John Ballem  March 23, 2021